Diamonds in the Rough
Cross-referencing fundamental value against technical exhaustion to isolate beaten-down VTI constituents that screen cheap and oversold. The bottom-right quadrant — high earnings yield, low RSI — is the prime hunting ground, especially where money flow (MFI) shows quiet accumulation despite the falling price.
Educational screen, not investment advice. “Diamond” classification is a mechanical valuation-vs-RSI split around the cohort median earnings yield and an RSI of 50.
Alpha Quadrant — Valuation × Technical Exhaustion
X = earnings yield (cheaper right) · Y = RSI 14 (more oversold lower) · bubble = market cap · color = money flow.
Diamond Candidates
Ranked by a composite of earnings yield, ROIC, oversold RSI, recent weakness, and improving money flow.
| # | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | INDV | Indivior Pharmaceuticals, Inc. Common Stock | 90.0 | 7.32% | 7.38 | 33 | -11.45% | 36 | safe |
| 2 | PRVA | Privia Health Group, Inc. Common Stock | 90.0 | 58.08% | 3.85 | 30 | -17.22% | 34 | safe |
| 3 | CMPR | Cimpress PLC Ordinary Shares (Ireland) | 88.8 | 6.96% | 2.90 | 36 | -11.23% | 39 | distress |
| 4 | XCUR | Exicure, Inc. Common Stock | 82.6 | 31.51% | 1.76 | 34 | -30.81% | 37 | distress |
| 5 | AMSF | AMERISAFE, Inc. | 81.4 | 13.62% | 1.64 | 31 | -14.28% | 14 | distress |
| 6 | BTMD | Biote Corp. Class A Common Stock | 80.7 | 22.88% | 1.74 | 42 | -30.40% | 56 | distress |
| 7 | CIA | Citizens, Inc. | 80.4 | 9.66% | 1.54 | 34 | -19.79% | 35 | distress |
| 8 | CINF | Cincinnati Financial Corp | 77.8 | 13.73% | 7.73 | 44 | -6.50% | 44 | safe |
| 9 | HMN | Horace Mann Educators Corporation | 76.0 | 9.02% | 3.81 | 47 | -3.02% | 54 | distress |
| 10 | COHN | Cohen & Company Inc | 76.0 | 12.67% | 1.27 | 38 | -16.79% | 47 | distress |
| 11 | HLI | Houlihan Lokey, Inc. | 75.9 | 6.56% | 1.91 | 47 | -9.17% | 59 | safe |
| 12 | YOU | Clear Secure, Inc. | 75.9 | 4.17% | 2.91 | 34 | -17.21% | 20 | safe |
| 13 | CURV | Torrid Holdings Inc. | 74.7 | 6.05% | 2.16 | 42 | -18.60% | 40 | distress |
| 14 | RDN | Radian Group Inc. | 74.3 | 14.17% | 295.78 | 46 | -4.88% | 43 | safe |
| 15 | LFT | Lument Finance Trust, Inc. | 74.3 | 12.04% | 1.86 | 46 | -13.08% | 48 | distress |
Short-Squeeze Watch
Constituents with the highest composite squeeze score — heavy short interest meeting price support.
| # | |||||||
|---|---|---|---|---|---|---|---|
| 1 | PLCE | Children's Place, Inc. | 99.8 | 51.28% | 14.00 | +9.80% | critical |
| 2 | RUM | RUM Group Inc. Class A Common Stock | 96.4 | 26.52% | 12.89 | +75.17% | critical |
| 3 | SEAT | Vivid Seats Inc. Class A Common Stock | 96.0 | 23.52% | 14.48 | +1.32% | critical |
| 4 | SMMT | Summit Therapeutics Inc. Common Stock | 94.5 | 26.36% | 8.86 | -3.54% | critical |
| 5 | SANA | Sana Biotechnology, Inc. Common Stock | 93.3 | 25.41% | 16.33 | +26.93% | critical |
| 6 | ZBIO | Zenas BioPharma, Inc. Common Stock | 93.3 | 40.32% | 13.83 | +9.25% | critical |
| 7 | IBRX | ImmunityBio, Inc. Common Stock | 93.2 | 35.04% | 14.49 | +12.97% | critical |
| 8 | IBTA | Ibotta, Inc. | 93.2 | 48.16% | 17.69 | +45.75% | critical |
| 9 | INBX | Inhibrx Biosciences, Inc. Common Stock | 92.9 | 35.96% | 15.64 | +48.55% | critical |
| 10 | PRME | Prime Medicine, Inc. Common Stock | 92.7 | 34.63% | 12.90 | +24.92% | critical |
| 11 | CRK | Comstock Resources, Inc. | 92.2 | 31.69% | 9.86 | +6.38% | critical |
| 12 | BBOT | BridgeBio Oncology Therapeutics, Inc. Common Stock | 91.2 | 23.49% | 20.77 | +4.11% | critical |
Market cap, valuation, and short-interest metrics are joined to the latest VTI holdings snapshot; each ticker links to its full quote and analysis page.